메뉴 건너뛰기




Volumn 112, Issue 2, 2013, Pages 162-168

Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for reduction of myocardial damage during angioplasty [ARMYDA-8 RELOAD-ACS] trial)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PLACEBO;

EID: 84879843496     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.03.008     Document Type: Article
Times cited : (16)

References (19)
  • 1
    • 0038649988 scopus 로고    scopus 로고
    • Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity
    • P.A. Gurbel, K.P. Bliden, B.L. Hiatt, and C.M. O'Connor Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913
    • (2003) Circulation , vol.107 , pp. 2908-2913
    • Gurbel, P.A.1    Bliden, K.P.2    Hiatt, B.L.3    O'Connor, C.M.4
  • 4
    • 4944261759 scopus 로고    scopus 로고
    • Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy
    • A. Kastrati, N. von Beckerath, A. Joost, G. Pogatsa-Murray, O. Gorchakova, and A. Schömig Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy Circulation 110 2004 1916 1919
    • (2004) Circulation , vol.110 , pp. 1916-1919
    • Kastrati, A.1    Von Beckerath, N.2    Joost, A.3    Pogatsa-Murray, G.4    Gorchakova, O.5    Schömig, A.6
  • 5
    • 53449091585 scopus 로고    scopus 로고
    • What to do with patients receiving long-term clopidogrel: Reload or relax?
    • D.O. Williams, and J.D. Abbott What to do with patients receiving long-term clopidogrel: reload or relax? Circulation 118 2008 1219 1222
    • (2008) Circulation , vol.118 , pp. 1219-1222
    • Williams, D.O.1    Abbott, J.D.2
  • 6
    • 77953178780 scopus 로고    scopus 로고
    • Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: Results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial
    • ARMYDA-4 RELOAD Investigators
    • G. Di Sciascio, G. Patti, V. Pasceri, G. Colonna, F. Mangiacapra, A. Montinaro ARMYDA-4 RELOAD Investigators Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial Eur Heart J 31 2010 1337 1343
    • (2010) Eur Heart J , vol.31 , pp. 1337-1343
    • Di Sciascio, G.1    Patti, G.2    Pasceri, V.3    Colonna, G.4    Mangiacapra, F.5    Montinaro, A.6
  • 8
    • 33745877645 scopus 로고    scopus 로고
    • Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel
    • A. Malinin, A. Pokov, L. Swaim, M. Kotob, and V. Serebruany Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel Methods Find Exp Clin Pharmacol 28 2006 315 322
    • (2006) Methods Find Exp Clin Pharmacol , vol.28 , pp. 315-322
    • Malinin, A.1    Pokov, A.2    Swaim, L.3    Kotob, M.4    Serebruany, V.5
  • 9
    • 33845474736 scopus 로고    scopus 로고
    • Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study
    • A. Malinin, A. Pokov, M. Spergling, A. Defranco, K. Schwartz, D. Schwartz, E. Mahmud, D. Atar, and V. Serebruany Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study Thromb Res 119 2007 277 284
    • (2007) Thromb Res , vol.119 , pp. 277-284
    • Malinin, A.1    Pokov, A.2    Spergling, M.3    Defranco, A.4    Schwartz, K.5    Schwartz, D.6    Mahmud, E.7    Atar, D.8    Serebruany, V.9
  • 11
    • 67650665776 scopus 로고    scopus 로고
    • Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: An analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
    • A. Prasad, B.J. Gersh, M.E. Bertrand, A.M. Lincoff, J.W. Moses, E.M. Ohman, H.D. White, S.J. Pocock, B.T. McLaurin, D.A. Cox, A.J. Lansky, R. Mehran, and G.W. Stone Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 54 2009 477 486
    • (2009) J Am Coll Cardiol , vol.54 , pp. 477-486
    • Prasad, A.1    Gersh, B.J.2    Bertrand, M.E.3    Lincoff, A.M.4    Moses, J.W.5    Ohman, E.M.6    White, H.D.7    Pocock, S.J.8    McLaurin, B.T.9    Cox, D.A.10    Lansky, A.J.11    Mehran, R.12    Stone, G.W.13
  • 12
    • 0023864355 scopus 로고
    • Thrombolysis in Myocardial Infarction (TIMI) trial - Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
    • A.K. Rao, C. Pratt, A. Berke, A. Jaffe, I. Ockene, T.L. Schreiber, W.R. Bell, G. Knatterud, T.L. Robertson, and M.L. Terrin Thrombolysis In Myocardial Infarction (TIMI) trial - phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11
    • (1988) J Am Coll Cardiol , vol.11 , pp. 1-11
    • Rao, A.K.1    Pratt, C.2    Berke, A.3    Jaffe, A.4    Ockene, I.5    Schreiber, T.L.6    Bell, W.R.7    Knatterud, G.8    Robertson, T.L.9    Terrin, M.L.10
  • 13
    • 53449098101 scopus 로고    scopus 로고
    • Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: The Reload with Clopidogrel before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) study
    • J.P. Collet, J. Silvain, A. Landivier, M.L. Tanguy, G. Cayla, A. Bellemain, N. Vignolles, S. Gallier, F. Beygui, A. Pena, and G. Montalescot Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) study Circulation 118 2008 1225 1233
    • (2008) Circulation , vol.118 , pp. 1225-1233
    • Collet, J.P.1    Silvain, J.2    Landivier, A.3    Tanguy, M.L.4    Cayla, G.5    Bellemain, A.6    Vignolles, N.7    Gallier, S.8    Beygui, F.9    Pena, A.10    Montalescot, G.11
  • 14
    • 0035849545 scopus 로고    scopus 로고
    • Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation
    • M.J. Ricciardi, E. Wu, C.J. Davidson, K.M. Choi, F.J. Klocke, R.O. Bonow, R.M. Judd, and R.J. Kim Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation Circulation 103 2001 2780 2783
    • (2001) Circulation , vol.103 , pp. 2780-2783
    • Ricciardi, M.J.1    Wu, E.2    Davidson, C.J.3    Choi, K.M.4    Klocke, F.J.5    Bonow, R.O.6    Judd, R.M.7    Kim, R.J.8
  • 15
    • 0142075775 scopus 로고    scopus 로고
    • Mortality risk conferred by small elevations of creatine-kinase MB isoenzyme after percutaneous intervention
    • J.P.A. Ioannidis, E. Karvouni, and D.G. Katritis Mortality risk conferred by small elevations of creatine-kinase MB isoenzyme after percutaneous intervention J Am Coll Cardiol 42 2003 1406 1411
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1406-1411
    • Ioannidis, J.P.A.1    Karvouni, E.2    Katritis, D.G.3
  • 16
    • 44349185490 scopus 로고    scopus 로고
    • Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease
    • T. Geisler, M. Kapp, K. Göhring-Frischholz, K. Daub, C. Dösch, B. Bigalke, H. Langer, C. Herdeg, and M. Gawaz Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease Heart 94 2008 743 747
    • (2008) Heart , vol.94 , pp. 743-747
    • Geisler, T.1    Kapp, M.2    Göhring-Frischholz, K.3    Daub, K.4    Dösch, C.5    Bigalke, B.6    Langer, H.7    Herdeg, C.8    Gawaz, M.9
  • 17
    • 0006870550 scopus 로고    scopus 로고
    • Platelet activation in patients after an acute coronary syndrome: Results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction
    • K.A. Ault, C.P. Cannon, J. Mitchell, J. McCahan, R.P. Tracy, W.F. Novotny, J.D. Reimann, and E. Braunwald Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction J Am Coll Cardiol 33 1999 634 639
    • (1999) J Am Coll Cardiol , vol.33 , pp. 634-639
    • Ault, K.A.1    Cannon, C.P.2    Mitchell, J.3    McCahan, J.4    Tracy, R.P.5    Novotny, W.F.6    Reimann, J.D.7    Braunwald, E.8
  • 19
    • 84856158305 scopus 로고    scopus 로고
    • ESC Committee for Practice Guidelines, J.J. Bax, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, A. Torbicki, A. Vahanian, S. Windecker, Document Reviewers, S. Windecker, S. Achenbach, L. Badimon, M. Bertrand, H.E. Bøtker, J.P. Collet, F. Crea, N. Danchin, E. Falk, J. Goudevenos, D. Gulba, R. Hambrecht, J. Herrmann, A. Kastrati, K. Kjeldsen, S.D. Kristensen, P. Lancellotti, J. Mehilli, B. Merkely, G. Montalescot, F.J. Neumann, L. Neyses, J. Perk, M. Roffi, F. Romeo, M. Ruda, E. Swahn, M. Valgimigli, C.J. Vrints, and P.
    • C.W. Hamm, J.P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, D. Dudek, S. Gielen, K. Huber, M. Ohman, M.C. Petrie, F. Sonntag, M.S. Uva, R.F. Storey, W. Wijns, D. Zahger, ESC Committee for Practice Guidelines, J.J. Bax, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, A. Torbicki, A. Vahanian, S. Windecker, Document Reviewers, S. Windecker, S. Achenbach, L. Badimon, M. Bertrand, H.E. Bøtker, J.P. Collet, F. Crea, N. Danchin, E. Falk, J. Goudevenos, D. Gulba, R. Hambrecht, J. Herrmann, A. Kastrati, K. Kjeldsen, S.D. Kristensen, P. Lancellotti, J. Mehilli, B. Merkely, G. Montalescot, F.J. Neumann, L. Neyses, J. Perk, M. Roffi, F. Romeo, M. Ruda, E. Swahn, M. Valgimigli, C.J. Vrints, and P. Widimsky The task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 32 2011 2999 3054
    • (2011) Eur Heart J , vol.32 , pp. 2999-3054
    • Hamm, C.W.1    Bassand, J.P.2    Agewall, S.3    Bax, J.4    Boersma, E.5    Bueno, H.6    Caso, P.7    Dudek, D.8    Gielen, S.9    Huber, K.10    Ohman, M.11    Petrie, M.C.12    Sonntag, F.13    Uva, M.S.14    Storey, R.F.15    Wijns, W.16    Zahger, D.17


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.